(Q37419880)

English

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy

scientific article published on February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

object named as

Hans Lilja

11

0 references

object named as

Andrew J Vickers

4

0 references

6

object named as

Howard I Scher

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Sven Wenske

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ruslan Korets

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Angel M Cronin

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Martin Fleisher

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kim Pettersson

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Bertrand Guillonneau

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Peter T Scardino

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

James A Eastham

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

124

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

659-663

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

23 August 2017

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

23 August 2017

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

28 September 2017

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

26 June 2018

Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

26 June 2018

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

26 June 2018

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

2 September 2018

Development of sensitive immunoassays for free and total human glandular kallikrein 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

2 September 2018

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

2 September 2018

Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

2 September 2018

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

2 September 2018

Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: an update.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

2 September 2018

Comparison of Free and Total Forms of Serum Human Kallikrein 2 and Prostate-Specific Antigen for Prediction of Locally Advanced and Recurrent Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2776773

3 December 2018

Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and total human glandular kallikrein 2 in patients with prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of prostate-specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free‐to‐total prostate‐specific antigen ratio as a predictor of non‐organ‐confined prostate cancer (stage pT3)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19003994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/IJC.23983

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37419880&oldid=2185988779"